Archive for Treatment
Ikervis Ciclosporin available in Scotland, UK.
The Scottish Medicines Consortium has completed its assessment of the use of ciclosporin 1mg/mL (0.1%) and advises NHS boards and Area Drug and Therapeutic Committees on its use in Scotland. (SMC No (1089/15). Ikervis Ciclosporin is used in the treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite […]
Thygesons Superficial Punctate Keratitis (TSPK) Treatment and Management
Various treatments have been used to try and treat Thygeson’s SPK; however, many have been unsuccessful. Antibiotics are not successful and are ineffective in treating the condition. In some instances antivirals have been used and have had mixed results resulting in mild improvements with the use of trifluridine. Contrary information also suggests that the use […]
Patient Diagnosis and Management of Thygeson’s Superficial Punctate Keratitis
Thygeson’s Superficial Punctate Keratitis (TSPK) is a chronic eye disease that has remissions and exacerbations for a few years to decades. Patients typically present with whitish-grey, intraepithelial corneal lesions with no or limited conjunctival involvement. While the etiology of the disease remains controversial, it does have a genetic association with HLA-DR3, which is an antigen […]
Cyclosporine Ophthalmic Emulsion 0.05% – Restatis by Allergan
Produced as a sterile, preservative-free emulsion made from a white powder, Cyclosporine acts as a topical immunomodulator that has an anti-inflammatory effect. While Cyclosporine is the active ingredient, there are a number of inactive ingredients including polysorbate 80, glycerin, carbomer copolymer type A, castor oil, purified water, and sodium hydroxide to adjust its pH level. […]
No Cyclosporine Eye Drops in the UK
There are benefits associated with the treatment of Thygeson’s SPK using Cyclosporine. However, it needs to be used at a low concentration level. The treatment appears beneficial, yet it is not marketed at low concentrations in the UK under the National Health Service. Discussions with a local consultant in Edinburgh suggests that while the long-term […]
Topical Therapy in Thygeson’s Superficial Punctate Keratitis
When someone is affected by the severity of Thygeson’s Superficial Punctate Keratitis or in any of its signs, symptoms, or following remission, various therapies are considered depending on the severity of the disease at the time the patient presents to the eye care specialist. Where a patient presents with a mild case, then they may […]
Corticosteroids and Cyclosporine Treatments for Thygeson’s SPK
Studying the opacities or lesions created by Thygeson’s SPK, also known as Thygeson’s Superficial Punctate Keratopathy, Thygeson’s Superficial Punctate Keratitis and TSPK, shows a crystalline appearance on the corneal surface that resemble snowflakes. They vary in location and fluctuate in numbers even on a weekly basis during a flare up of the condition affecting the […]
Patient Education Relating to Thygeson’s Superficial Punctate Keratitis (TSPK)
Patient education relating to Thygeson’s Superficial Punctate Keratitis (TSPK) is an ongoing process that begins with diagnosis and continues through the entire term of the patient-doctor relationship as the patient battles the disease, attempting to manage the disease long-term. The cause or causes of Thygeson’s Superficial Punctate Keratitis (TSPK) have not yet been determined, but […]
Thygeson’s Superficial Punctate Keratitis (TSPK) Treatment Complications
The good news is that Thygeson’s Superficial Punctate Keratitis (TSPK) complications are far fewer than when the disease was first presented to the medical community in 1950.There are irritating symptoms such as chronic dry eye, burning sensations that come and go in the eyes, a high degree of sensitivity to bright lights or even sunshine […]
Followup Care for Thygeson’s Superficial Punctate Keratitis Patients
Thygeson’s Superficial Punctate Keratitis (TSPK) patients will find out that the cause of this disease has eluded the medical community around the world for over 60 years. During that over half a century there has been many experiments and case studies conducted to determine how to best diagnose, treat, and provide followup care for TSPK […]